Colgate-Palmolive Company
CL NYSEConsumer Defensive ★★★★★Latest Earnings
Date
Jul 31, 2026
ET
EPS Est.
0.95
EPS Actual
0.99
Revenue Est.
$5.36B
Revenue Actual
$5.36B
Next Earnings Report
Date
Oct 30, 2026 · Fri
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
0.92
Revenue Est.
$5.34B
Company Overview
Colgate-Palmolive Company (ticker CL) is listed on NYSE with a market cap of about $72.88B. Its next earnings report (FY2026 Q3) is expected on Oct 30, 2026 (ET), Pre-market, with consensus EPS of 0.92. In the last 15 reported quarters, EPS beat consensus estimates 14 times.
Actual EPS TrendRecently15Term · Jan 27, 2023 → Jul 31, 2026
Jan 27, 2023Range: 0.73 ~ 0.99Jul 31, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 31, 2026 | -- | 0.95 | 0.99 | $5.36B | $5.36B |
| May 1, 2026 | -- | 0.94 | 0.97 | $5.22B | $5.32B |
| Jan 30, 2026 | -- | 0.91 | 0.95 | $5.12B | $5.23B |
| Oct 31, 2025 | -- | 0.89 | 0.91 | $5.13B | $5.13B |
| Aug 1, 2025 | -- | 0.90 | 0.92 | $5.04B | $5.11B |
| Apr 25, 2025 | -- | 0.86 | 0.91 | $4.87B | $4.91B |
| Jan 31, 2025 | -- | 0.90 | 0.91 | $4.98B | $4.95B |
| Oct 25, 2024 | -- | 0.89 | 0.91 | $5.01B | $5.03B |
| Jul 26, 2024 | -- | 0.87 | 0.91 | $5B | $5.06B |
| Apr 26, 2024 | -- | 0.81 | 0.86 | $4.96B | $5.07B |
| Jan 26, 2024 | -- | 0.85 | 0.87 | $4.89B | $4.95B |
| Oct 27, 2023 | -- | 0.80 | 0.86 | $4.82B | $4.92B |
| Jul 28, 2023 | -- | 0.75 | 0.77 | $4.69B | $4.82B |
| Apr 28, 2023 | -- | 0.70 | 0.73 | $4.58B | $4.77B |
| Jan 27, 2023 | -- | 0.77 | 0.77 | $4.59B | $4.63B |
Original Filings (SEC)
10-Q2026-07-31 ↗
8-K2026-07-31 ↗
8-K2026-05-13 ↗
8-K2026-04-09 ↗
8-K2026-03-17 ↗
8-K2026-03-12 ↗
10-K2026-02-23 ↗
8-K2026-01-30 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
